“luspatercept” Archives

in
Entry Author Date Location
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Acceleron Drops Drug for Rare Muscle Disease After Mixed Phase 2 Data 03/10/20 Boston
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval 11/08/19 New York
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Celgene Files for FDA Approval of Blood Disease Drug 04/05/19 New York
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder 07/09/18 Boston
Acceleron’s Blood Drug Hits Phase 3 Goals, Paves Way for FDA Filing 06/28/18 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
Page 1 of 1